A substantial advancement in diabetes treatment is emerging with the introduction of tirzepatide at a dosage of 45mg. This updated version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 target, https://bookmarkgenious.com/story21450436/revolutionary-development-tirzepatide-strength-for-diabetes-regulation